4.29
Vistagen Therapeutics Inc (VTGN) 最新ニュース
Why Vistagen Therapeutics Inc. stock is trending among retail tradersJuly 2025 Final Week & Free Community Consensus Stock Picks - Newser
Will Vistagen Therapeutics Inc. stock pay special dividends2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
VistaGen Therapeutics (NASDAQ:VTGN) Stock Price Passes Below 50 Day Moving AverageHere's Why - MarketBeat
VistaGen appoints Nick Tressler as CFO - MSN
Vistagen Appoints Nick Tressler as Chief Financial Officer - PharmiWeb.com
The time has not yet come to remove your chips from the table: Vistagen Therapeutics Inc (VTGN) - Setenews
Vistagen Therapeutics Appoints Nick Tressler as CFO - MarketScreener
Vistagen (VTGN) Appoints New CFO, Nick Tressler - GuruFocus
Vistagen (VTGN) Names Nick Tressler as New CFO - GuruFocus
Vistagen Names Nick Tressler as Chief Financial Officer - Contract Pharma
Vistagen appoints Nick Tressler as chief financial officer - marketscreener.com
Vistagen (Nasdaq: VTGN) appoints CFO Nick Tressler, grants 150,000-share option - Stock Titan
Why retail investors pile into Vistagen Therapeutics Inc. stock2025 Sector Review & Technical Pattern Based Signals - BỘ NỘI VỤ
Vistagen Therapeutics Inc. (VTGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vistagen (VTGN) Presents Promising Data on PH80 for Menopause Sy - GuruFocus
Vistagen presents data on PH80 for menopausal hot flashes treatment By Investing.com - Investing.com Canada
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting - Yahoo Finance
Form 8-KCurrent report - ADVFN
Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update - ADVFN
What analysts say about Vistagen Therapeutics Inc stockTop Performing Stocks & Free ETF and Mutual Fund Comparisons - earlytimes.in
Is Vistagen Therapeutics Inc a good long term investmentTechnical Breakout Signals & High Return Capital Strategies - earlytimes.in
Can Vistagen Therapeutics Inc. stock hit analyst price targetsSwing Trade & Expert Verified Stock Movement Alerts - newser.com
What technical charts say about Vistagen Therapeutics Inc. stockJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - newser.com
Will Vistagen Therapeutics Inc. stock split attract more investorsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
ETFs Investing in Vistagen Therapeutics, Inc. Stocks - TradingView
Can Vistagen Therapeutics Inc. stock deliver surprise earnings beatQuarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Will Vistagen Therapeutics Inc. stock deliver shareholder valueQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
How Vistagen Therapeutics Inc. stock compares to industry benchmarksQuarterly Market Review & Precise Trade Entry Recommendations - newser.com
Is Vistagen Therapeutics Inc. stock attractive for income investorsGold Moves & AI Driven Stock Movement Reports - newser.com
Is Vistagen Therapeutics Inc. a candidate for recovery play2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com
Using RSI to spot recovery in Vistagen Therapeutics Inc.Market Performance Report & AI Powered Buy and Sell Recommendations - newser.com
Is Vistagen Therapeutics Inc. stock a safe haven assetBear Alert & Low Risk High Win Rate Stock Picks - newser.com
Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026 (NASDAQ:VTGN) - Seeking Alpha
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Stifel reiterates Buy rating on VistaGen stock, maintains $12 price target - Investing.com Nigeria
Vistagen Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com
大文字化:
|
ボリューム (24 時間):